What Is Obstetrics? Medical Care in Pregnancy and Birth

Obstetrics is the medical specialty devoted to pregnancy, labor, delivery, and the period immediately afterward. It sounds simple in summary, but the field sits at a remarkably busy intersection of surgery, internal medicine, genetics, immunology, and mental health. A pregnant person’s body undergoes changes to nearly every organ system over roughly 40 weeks, and the clinician’s job is to anticipate, detect, and manage the complications that can arise at each stage. Modern obstetrics has been reshaped by advances in prenatal screening, standardized safety protocols, fetal surgery performed before birth, and a growing understanding of why disparities in maternal outcomes persist even in wealthy countries.

How Prenatal Screening Has Changed

One of the most significant shifts in early pregnancy care over the past decade has been the arrival of cell-free DNA testing, sometimes called noninvasive prenatal testing (NIPT). During pregnancy, fragments of fetal DNA circulate in the mother’s blood. A simple blood draw can now screen for chromosomal conditions with accuracy that older methods could not approach. A large trial comparing cell-free DNA analysis with traditional first-trimester screening for Down syndrome found that the newer test detected all affected pregnancies, versus about four in five detected by standard screening. The false positive rate dropped from over 5 percent to less than one-tenth of a percent, and the positive predictive value jumped from roughly 3 percent to over 80 percent.

A systematic meta-analysis pooling data from more than 148,000 tests confirmed similarly high sensitivity and specificity for trisomy 21 and trisomy 18, with somewhat lower but still strong performance for rarer conditions like monosomy X and trisomy 13.² What this means in practice is that far fewer pregnant people are referred for amniocentesis or chorionic villus sampling, both of which carry a small risk of miscarriage. It does not eliminate the need for confirmatory testing when a screen comes back positive, but it has dramatically reduced unnecessary invasive procedures and the anxiety that goes with them.

Preeclampsia and Blood Pressure in Pregnancy

Preeclampsia, a syndrome of high blood pressure and organ damage that develops after 20 weeks of pregnancy, remains one of the leading causes of maternal and fetal death worldwide. The root of the problem traces back to the earliest weeks: abnormal development of the placenta leads to poor blood flow, which triggers a cascade of vascular dysfunction in the mother. A key player in that cascade is a protein called sFlt-1, which mops up growth factors in the mother’s bloodstream that her blood vessels need to stay healthy. The ratio of sFlt-1 to one of those growth factors, PlGF, reflects how severe the imbalance is.³ Research has shown that elevated sFlt-1 levels and a high sFlt-1/PlGF ratio constitute independent risk factors for preeclampsia.⁴

Preeclampsia is also linked to higher pre-pregnancy body weight: women who develop the condition tend to have higher BMI both before and during pregnancy, and their sFlt-1-to-PlGF ratios run roughly three times higher than in uncomplicated pregnancies.⁵ Clinically, the most dangerous risk is that uncontrolled blood pressure can lead to stroke. A hospital system that implemented automatic, rapid treatment whenever blood pressure crossed defined thresholds eliminated in-hospital deaths from intracranial hemorrhage related to preeclampsia and cut overall preeclampsia deaths from 15 to 3 across more than a million deliveries.⁶ That finding underscores a painful truth about obstetric safety: many deaths are preventable, and what often stands in the way is not a lack of technology but a lack of consistent protocols.

Safety Bundles and Hemorrhage Protocols

Obstetric hemorrhage, the most common cause of severe maternal morbidity, is another area where standardized care has made a measurable difference. When hospitals implement comprehensive hemorrhage protocols, the results can be striking. One large study found a significant shift toward bleeding being controlled at an earlier stage, a drop in blood-product use, and a 64 percent reduction in the rate of disseminated intravascular coagulation, a dangerous clotting disorder.⁷ Staff and physician perceptions of patient safety improved alongside the clinical outcomes, suggesting that having a clear playbook helps teams act faster and more confidently in emergencies.

These gains are not limited to hemorrhage. The concept of “safety bundles,” which package together the best evidence-based practices for specific emergencies, has been extended to severe hypertension as well. Consistent implementation of hemorrhage and hypertension bundles in collaborative, team-based settings reduces adverse outcomes.⁸ The recurring theme is that the science behind each individual intervention already exists; what changes outcomes is making sure every team member follows the same steps in the same order, every time.

Labor Induction and Cervical Ripening

Not every pregnancy ends with spontaneous labor. When induction is needed, clinicians choose between mechanical methods, like placing a balloon catheter through the cervix, and pharmacological agents such as prostaglandins. Both approaches work, but their safety profiles differ. A systematic review comparing double-balloon catheters with prostaglandin E2 found that the two methods led to similar cesarean rates and similar odds of vaginal delivery within 24 hours, but women receiving prostaglandins had a roughly tenfold higher risk of excessive uterine activity and a higher rate of neonatal intensive care admissions.⁹

A large randomized trial comparing a silicone double-balloon catheter with a slow-release dinoprostone pessary showed no meaningful difference in cesarean rates for concerning fetal heart tracings. Pharmacological ripening did produce a shorter time from induction to delivery, by about nine hours, but fewer women in the mechanical group needed pain medication during the ripening phase.¹⁰ The trade-off is straightforward: the balloon takes longer but causes fewer side effects, while prostaglandins are faster but come with more risk of overstimulating the uterus. The choice often depends on the clinical scenario and the individual patient.

Epidural Analgesia During Labor

Epidurals are the most effective form of labor pain relief, but their effects on labor itself have been debated for decades. A quantitative review of multiple study designs found that epidural analgesia doubled the likelihood of needing oxytocin to augment labor. The picture diverged depending on study type: clinical trials did not show a higher cesarean rate with epidurals, but observational studies reported over a fourfold increase. Most studies showed longer labor, especially in the second stage, though statistical methods varied widely.¹¹

A more recent real-world study of 400 first-time mothers found that the median total labor duration was about two and a half hours longer with epidural analgesia, and both the first and second stages were individually longer. Importantly, though, delivery modes and newborn outcomes were not statistically different between the two groups.¹² The practical takeaway for most people is that an epidural will likely make labor longer but is not associated with worse outcomes for the baby. The idea that getting an epidural “too early” automatically leads to a cesarean is not well supported by randomized evidence.

Fetal Monitoring and Its Limits

Continuous electronic fetal heart rate monitoring is ubiquitous in labor wards, but the technology has real limitations that deserve honest discussion. Its strength is specificity: a normal tracing is reassuring. Its weakness is sensitivity. One study found that even expert reviewers, aided by computer algorithms, would have recommended earlier intervention in fewer than half of cases that ultimately resulted in newborn metabolic acidemia, a marker of oxygen deprivation.¹³ Among the cases experts judged as not warranting earlier delivery, the most common scenarios involved sudden events like prolonged decelerations just before delivery, or tracings that deteriorated too rapidly for anyone to realistically intervene in time.

This does not mean monitoring is useless. It means that expecting it to catch every case of fetal distress sets up an unrealistic standard. Some adverse events happen too quickly for any monitoring system to prevent, regardless of how attentively the tracing is watched.

Cesarean Delivery and Trying for a Vaginal Birth After One

Cesarean births account for roughly one in three deliveries in many high-income countries, and a major clinical question is what happens with subsequent pregnancies. Vaginal birth after cesarean (VBAC) is a reasonable option for many, but it carries a small risk of uterine rupture. A review of twin pregnancies found that women who attempted VBAC had a uterine rupture rate under 1 percent, compared with about 0.1 percent for those who chose a planned repeat cesarean.¹⁴ Even among women with three or more prior cesareans, those who attempted VBAC had success rates and maternal complication profiles comparable to women with only one prior cesarean, with about an 80 percent success rate.¹⁵

An important nuance is that a prior vaginal delivery changes the equation. Among VBAC candidates who had previously delivered vaginally, those who attempted another vaginal birth were actually less likely to experience major complications, develop a fever, or require a blood transfusion compared with those who opted for a repeat cesarean.¹⁶ The decision is highly individual, but the blanket notion that “once a cesarean, always a cesarean” does not reflect the evidence.

Preventing Postpartum Hemorrhage

Oxytocin given right after delivery is the single most effective intervention for reducing postpartum bleeding. A Cochrane review found that prophylactic oxytocin cut the risk of hemorrhage roughly in half and reduced the need for additional uterine-contracting drugs by a similar margin.¹⁷ That benefit extends to settings outside hospitals: in non-facility births, oxytocin still roughly halved the incidence of hemorrhage compared to no treatment.¹⁸

Adding misoprostol on top of routine oxytocin, however, does not appear to help. A randomized trial was stopped early after an interim analysis showed no reduction in hemorrhage when misoprostol was added to oxytocin, while side effects climbed sharply: fever occurred in about 30 percent of women receiving misoprostol compared with 6 percent on placebo, and shivering rates jumped from under 1 percent to about 11 percent.¹⁹ Misoprostol retains an important role in settings where oxytocin is not available, but doubling up the two drugs is not the answer.

Group B Strep Screening and Newborn Infection

Group B Streptococcus (GBS) is a bacterium that lives harmlessly in the vaginal or rectal tracts of roughly a quarter of pregnant women but can cause serious bloodstream infections in newborns during delivery. Routine screening late in pregnancy, followed by intravenous antibiotics during labor for women who test positive, has driven major reductions in neonatal GBS disease over the past three decades.²⁰

A recent study at a center with 97 percent adherence to universal screening found that GBS-positive women had over five times the risk of neonatal sepsis compared with non-carriers. Among term babies delivered vaginally, giving antibiotics at least four hours before birth cut the risk of neonatal sepsis by about 71 percent. The benefit was similar for term babies born by cesarean after antenatal antibiotic treatment.²¹ Timing matters: antibiotics given less than four hours before delivery are less effective, which is why clinicians push to administer them early once labor begins in a GBS-positive patient.

Fetal Surgery for Twin-to-Twin Transfusion

Perhaps the most dramatic frontier in obstetrics is operating on the fetus before it is born. Twin-to-twin transfusion syndrome occurs in identical twins sharing a placenta when abnormal blood vessel connections allow blood to flow unevenly between them. Left untreated, it can be fatal for one or both twins. The standard treatment for severe cases is fetoscopic laser surgery, in which a tiny scope is inserted through the mother’s abdomen and the offending blood vessels on the placental surface are sealed with a laser beam.²²

Compared with repeated drainage of excess amniotic fluid, laser treatment produces a higher proportion of pregnancies with at least one surviving baby (about 79 percent versus 60 percent), fewer cases of both twins dying before birth, and lower rates of abnormal brain findings in surviving newborns.²³ Not all cases require surgery, though. In the earliest, mildest stage of the syndrome, a randomized trial found that immediate laser surgery and watchful waiting produced similar rates of intact survival at six months, with over 40 percent of the watched cases remaining stable without ever needing intervention.²⁴ Knowing when to operate and when to wait is one of the harder judgment calls in the field.

IVF Pregnancies and Obstetric Risk

Pregnancies conceived through in vitro fertilization carry a distinct obstetric risk profile. A nationwide study in China found that IVF pregnancies were roughly twice as likely to involve placenta previa and placenta accreta (where the placenta grows too deeply into the uterine wall), and the rates of preeclampsia, preterm birth, and fetal growth restriction were all significantly elevated even after adjusting for maternal age and chronic health conditions.²⁵ A separate analysis identified IVF as an independent risk factor for placenta accreta spectrum disorders even when accounting for prior cesarean delivery and placenta previa, both of which are themselves strong predictors.²⁶

A meta-analysis of 72 cohort studies estimated the pooled preeclampsia risk among women who conceived with assisted reproductive technology at about 11 percent.²⁷ None of this means IVF pregnancies are unsafe; millions proceed without serious complications. But it does mean that these pregnancies warrant closer surveillance, including earlier and more frequent imaging of placental position, and a lower threshold for screening for hypertensive disorders.

Racial and Socioeconomic Disparities in Maternal Outcomes

The evidence on disparities in obstetric care is difficult to read and impossible to ignore. In the United States, Black women in 2018 had a 2.4 times higher risk of dying from pregnancy-related causes than White women, a gap that persisted across five decades of data. Unmarried status, lower educational attainment, and rural residence were each associated with 50 to 114 percent higher maternal mortality risks. And mothers living in the most economically deprived areas had a 120 percent higher risk of death than those in the most affluent areas, with that gap widening between 2002 and 2018.²⁸

These disparities do not disappear after controlling for medical risk factors. An analysis that adjusted for comorbidities including high-risk pregnancy, hypertension, diabetes, and opioid use disorder still found that Black women’s hospital admissions were over twice as likely to result in maternal death or miscarriage compared with White women’s.²⁹ Neighborhood-level socioeconomic disadvantage is an independent contributor as well: women in the most disadvantaged areas had nearly 80 percent higher odds of severe maternal morbidity or death, and being non-Hispanic Black or having government insurance further increased risk.³⁰ The causes are structural and multifactorial, involving access to care, implicit bias, chronic stress, hospital quality, and insurance coverage. No single intervention solves them, which is part of why progress has been so slow.

Preterm Labor and Why It Happens

Preterm birth, delivery before 37 weeks, affects roughly one in ten pregnancies and is the leading cause of death and disability in young children. At its core, labor, whether term or preterm, is an inflammatory process. As pregnancy advances, the mother’s inflammatory burden gradually increases in response to hormonal, metabolic, and physical signals, eventually leading to a functional withdrawal of progesterone’s calming effect on the uterus. That withdrawal, combined with rising inflammation, triggers contractions and cervical opening.³¹

In preterm labor, that same cascade fires too early, often because of infection, poor blood flow between the placenta and uterus, or abnormalities in progesterone signaling.³² The vaginal microbiome plays into this story as well. During a healthy pregnancy, the vaginal bacterial community tends to shift toward domination by Lactobacillus species, which produce lactic acid and keep the environment hostile to pathogens. By the third trimester, most women have low-diversity, Lactobacillus-rich microbiomes that are associated with lower rates of ascending infection and preterm birth.³³ When that microbial shift does not happen, or when pathogenic bacteria dominate, the risk of preterm labor rises.

Fetal Growth Restriction and Doppler Surveillance

When a fetus is not growing as expected, clinicians rely heavily on ultrasound Doppler measurements of blood flow through the umbilical cord to decide when to deliver. A summary of randomized and quasi-randomized studies found that using umbilical artery Doppler in high-risk pregnancies with suspected growth restriction reduced perinatal deaths by about 29 percent and decreased the rate of labor induction and cesarean delivery compared with standard monitoring.³⁴

Growth restriction that develops early in pregnancy tends to behave differently from that diagnosed later. In one study, early-onset growth-restricted fetuses showed abnormal umbilical artery Doppler findings, including absent or reversed blood flow, at about twice the rate of late-onset cases.³⁵ Early-onset restriction is typically driven by severe placental dysfunction and carries worse outcomes; late-onset cases are more common and often have a milder placental component. The distinction matters because it shapes how closely the pregnancy is monitored and when delivery is planned.

The Evolutionary Puzzle of Human Childbirth

Humans are unusual among primates in how difficult childbirth can be, and the evolutionary explanation for this has been debated since the 1960s. The classic “obstetrical dilemma” hypothesis holds that walking upright narrowed our pelvis while our growing brains demanded larger skulls, creating a tight fit during delivery.³⁶ Recent genetic evidence has added texture to this idea. A study using deep learning on over 31,000 body scans identified 180 genetic locations associated with pelvic shape and found that birth canal dimensions show sex-specific genetic architecture consistent with reproductive function. Larger birth canals were linked to slower walking pace and a higher risk of hip osteoarthritis, while narrower canals were associated with reduced pelvic floor disorders but increased risk of obstructed labor.³⁷

That same study found genetic correlation between birth canal width and head width, which suggests that the pelvis and brain have been coevolving, partially offsetting the mismatch. The pelvic shape difference between sexes also has a developmental timeline: the female pelvis widens during puberty and narrows after menopause, tracking the window of reproductive function.³⁸ The dilemma, in other words, is real but not as stark as once imagined. Evolution has partially, if imperfectly, solved it.

Pelvic Floor Consequences of Delivery

One area that tends to get less attention than it deserves is what happens to the pelvic floor after childbirth. Vaginal delivery is strongly associated with stress urinary incontinence and pelvic organ prolapse, conditions that can emerge years later. Disruption or nerve damage to the levator ani muscles, the main muscular hammock supporting the pelvic organs, is a key mechanism. A history of more than one perineal tear increases the likelihood of developing prolapse, though episiotomy has not been shown to carry the same association.³⁹

A cross-sectional study comparing pelvic floor outcomes six years after uncomplicated vaginal delivery versus elective cesarean found that women who had vaginal births were more likely to report urge incontinence and leakage during physical activity. Women who had cesarean deliveries, on the other hand, were more likely to report lower abdominal pain. Overall, over three-quarters of women who delivered vaginally reported at least one pelvic floor symptom at the six-year mark, compared with about two-thirds of those who had cesareans.⁴⁰ These figures do not mean that cesarean delivery should be chosen purely for pelvic floor protection; the trade-offs involve surgical risks, recovery time, and implications for future pregnancies. But they do suggest that pelvic floor rehabilitation after vaginal delivery is underused relative to the need.

How the Immune System Tolerates a Pregnancy

From an immunological standpoint, pregnancy is a paradox. The fetus carries genetic material from both parents, which means half of its proteins should look foreign to the mother’s immune system. Yet outright immune rejection is rare. The placenta builds multiple layers of defense: it acts as a physical barrier, restricts the migration of maternal immune cells, and limits how much fetal tissue is exposed to the mother’s immune surveillance. The maternal side, in turn, develops specialized populations of regulatory T cells and modified natural killer cells at the implantation site that promote tolerance rather than attack.⁴¹

When this system breaks down, the consequences are more often inflammatory than immunological in the classic sense. Miscarriage is more frequently caused by inflammation within the placenta than by the adaptive immune system actively rejecting the fetus.⁴² This helps explain why conditions like preeclampsia and preterm labor, both driven in part by inflammation, are so intertwined with immune function at the placental interface. The field of reproductive immunology is still mapping out exactly how each layer of tolerance works and how failures in one layer cascade into clinical disease.

1
PubMed. Cell-free DNA Analysis for Noninvasive Examination of Trisomy ↩︎
2
PubMed. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis ↩︎
3
PubMed. Angiogenic balance (sFlt-1/PlGF) and preeclampsia ↩︎
4
PubMed. Evaluation of the angiogenic factors sFlt-1, PlGF, and the sFlt-1/PlGF ratio in preeclampsia and associated features ↩︎
5
PubMed Central. Angiogenic Imbalance in Preeclampsia: Profiling VEGF A, sFlt1, PlGF, and sFlt1/PlGF Ratios ↩︎
6
PubMed. Maternal mortality in the United States: predictability and the impact of protocols on fatal postcesarean pulmonary embolism and hypertension-related intracranial hemorrhage ↩︎
7
PubMed. Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products ↩︎
8
PubMed Central. Enhancing Obstetric Safety Through Best Practices ↩︎
9
PubMed. Double-balloon catheter versus prostaglandin E2 for cervical ripening and labour induction: a systematic review and meta-analysis of randomised controlled trials ↩︎
10
PLOS Medicine. Cervical ripening in prolonged pregnancies by silicone double balloon catheter versus vaginal dinoprostone slow release system: The MAGPOP randomised controlled trial ↩︎
11
PubMed. Epidural analgesia in association with duration of labor and mode of delivery: a quantitative review ↩︎
12
PubMed Central. Epidural analgesia during labor and its optimal initiation time-points: A real-world study on 400 Chinese nulliparas ↩︎
13
PubMed. The limits of electronic fetal heart rate monitoring in the prevention of neonatal metabolic acidemia ↩︎
14
PubMed Central. Risk of Uterine Rupture with Vaginal Birth after Cesarean in Twin Gestations ↩︎
15
PubMed. Vaginal birth after caesarean for women with three or more prior caesareans: assessing safety and success ↩︎
16
PubMed. Is vaginal birth after cesarean (VBAC) or elective repeat cesarean safer in women with a prior vaginal delivery? ↩︎
17
Cochrane Database of Systematic Reviews. Prophylactic oxytocin for the third stage of labour ↩︎
18
PubMed Central. Oxytocin for preventing postpartum haemorrhage in non‐facility birth settings ↩︎
19
Obstetrics & Gynecology. Active Management of the Third Stage of Labor With a Combination of Oxytocin and Misoprostol to Prevent Postpartum Hemorrhage: A Randomized Controlled Trial ↩︎
20
PubMed Central. Neonatal Group B Streptococcus Disease ↩︎
21
PubMed Central. How can we reduce neonatal sepsis after universal group B streptococcus screening? ↩︎
22
PubMed Central. Laser for twin-to-twin transfusion syndrome: a guide for endoscopic surgeons ↩︎
23
PubMed. Endoscopic laser surgery versus serial amniocenteses in the treatment of severe twin-twin transfusion syndrome ↩︎
24
PubMed. Intrauterine fetoscopic laser surgery versus expectant management in stage 1 twin-twin transfusion syndrome: an international randomized trial ↩︎
25
PubMed Central. Placental Abnormalities and Placenta-Related Complications Following In-Vitro Fertilization: Based on National Hospitalized Data in China ↩︎
26
American Journal of Obstetrics and Gynecology. In vitro fertilization as an independent risk factor for placenta accreta spectrum ↩︎
27
PubMed. Risk of preeclampsia following assisted reproductive technology: systematic review and meta-analysis of 72 cohort studies ↩︎
28
PubMed Central. Maternal Mortality Trends and Social Inequalities in Maternal Mortality in the United States, 1969-2018 ↩︎
29
PubMed Central. Disparities in maternal mortality ↩︎
30
PubMed Central. Relationship Between Neighborhood Socioeconomic Disadvantage and Severe Maternal Morbidity and Maternal Mortality ↩︎
31
PubMed. Intrauterine inflammatory activation, functional progesterone withdrawal, and the timing of term and preterm birth ↩︎
32
PubMed. Progesterone, inflammation and preterm labor ↩︎
33
PubMed Central. The Vaginal Microbiota of Pregnant Women Varies with Gestational Age, Maternal Age, and Parity ↩︎
34
American Journal of Obstetrics and Gynecology. Doppler assessment of the fetus with intrauterine growth restriction ↩︎
35
PubMed Central. Ultrasound Evaluation of Fetal Biometry and Doppler Parameters in the Third Trimester of Pregnancy Suspected of Intrauterine Growth Restriction ↩︎
36
PubMed Central. The obstetrical dilemma hypothesis: there’s life in the old dog yet ↩︎
37
PubMed. The genetic architecture of and evolutionary constraints on the human pelvic form ↩︎
38
PubMed Central. Developmental evidence for obstetric adaptation of the human female pelvis ↩︎
39
PubMed Central. Pelvic floor disorders following vaginal or cesarean delivery ↩︎
40
Scientific Reports. Comparison of pelvic floor dysfunction 6 years after uncomplicated vaginal versus elective cesarean deliveries: a cross-sectional study ↩︎
41
PubMed Central. Multi-Layered Mechanisms of Immunological Tolerance at the Maternal-Fetal Interface ↩︎
42
PubMed Central. Tolerance of the fetus by the maternal immune system: role of inflammatory mediators at the feto-maternal interface ↩︎